Wealthcare Capital Partners’s AbbVie ABBV Stock Holding History

Wealthcare Capital Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Buy	1,184 +2	+0.2%	+$430	0.12%	134
2026 Q1	$257K	Buy	1,182 +64	+6%	+$14.2K	0.12%	134
2025 Q4	$255K	Sell	1,118 -244	-18%	-$55.6K	0.12%	127
2025 Q3	$315K	Buy	1,362 +3	+0.2%	+$611	0.15%	113
2025 Q2	$252K	Buy	1,359 +104	+8%	+$19.3K	0.13%	126
2025 Q1	$263K	Buy	+1,255	New	+$244K	0.14%	108

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealthcare Capital Partners's ABBV Position: Q2 2026 in Review

Wealthcare Capital Partners increased its AbbVie (ABBV) stake by 0.17% in Q2 2026, buying an estimated $430 and bringing the position to 1,184 shares worth $298K. The position accounts for 0.12% of the portfolio, ranked #134.

Wealthcare Capital Partners first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $315K in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Wealthcare Capital Partners held 1,184 shares of AbbVie worth $298K as of Q2 2026.
Wealthcare Capital Partners bought 2 AbbVie shares in Q2 2026, an estimated $430.
AbbVie made up 0.12% of Wealthcare Capital Partners's portfolio in Q2 2026, its #134 holding.
Wealthcare Capital Partners first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
Wealthcare Capital Partners's AbbVie position peaked at $315K in Q3 2025.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealthcare Capital Partners's 13F filing for Q2 2026, filed 9 Jul 2026.